Sanderling Venture Partners VI LP, 10% Owner at Pacira Pharmaceuticals, Inc. (PCRX), sold 374,511 shares at $25.92 ($10.4M) on 2013-03-07, disclosed to the SEC on 2013-03-11.
Open-market sale of $10.4M PCRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.92 | 66 | $2K | 0.0% |
| 2 | $25.92 | 78 | $2K | 0.0% |
| 3 | $25.92 | 368 | $10K | 0.1% |
| 4 | $25.92 | 438 | $11K | 0.1% |
| 5 | $25.92 | 1,852 | $48K | 0.5% |
| 6 | $25.92 | 1,866 |
| $48K |
| 0.5% |
| 7 | $25.92 | 10,407 | $270K | 2.6% |
| 8 | $25.92 | 10,485 | $272K | 2.6% |
| 9 | $27.86 | 348,951 | $9.7M | 93.6% |
| Total | $27.73 avg | 374,511 | $10.4M | 100% |
| Filing → |
| PCRX | BUY | 2011-02-10 | $325K | — | Filing → |